Triple negative breast cancer is often resistant to standard chemotherapy and disproportionately affects younger women, Black women and patients from underserved populations. But hope is on the horizon, thanks to the Mass General Cancer Center.
A new groundbreaking study, led by Mass General scientists, identifies 13 gene mutations that can provide important clues for restoring communication in the brain.
Searching for answers to her daughter’s rare genetic condition, a mother discovers the resources and support she needs at Mass General.
Lymph node swelling is a common side effect of the COVID-19 vaccine. The Lymphedema Research Program team aims to educate patients and healthcare providers and study patient experiences with the vaccine.
Mass General Cancer Center global immunology program connects respected researchers with the next generation of scientists.
With the help of cancer patients like Joe Sutton, Mass General’s Termeer Center is developing tomorrow’s breakthrough therapies.
Chief Learning Officer James Gordon, MD, MPA, describes how Mass General shared its COVID-19 knowledge with the world and explains why a “digital library” could provide a foundation for broader educational efforts.
Mass General Psychiatrist-in-Chief Emeritus Jerrold F. Rosenbaum, MD, explains the promising science behind psychedelic medicine.
Thanks to the efforts of Mass General imaging physicist Matt Rosen, PhD, low-cost portable MRI devices could soon transform global health care.
Jerry and Phyllis Rappaport, longtime supporters of Mass General, expand their commitment to mental illness and neurodegenerative disease research.